Plasma lipids, lipoproteins, and blood pressure in female adolescents using oral contraceptives

The Journal of Pediatrics

Volumn 95, Issue 6, 1979, Pages 1055-1059

  Wallace, R B ^a   Tamir, I ^b   Heiss, G ^c   Rifkind, B M ^b   Christensen, B ^d   Glueck, C J ^e  

^a UNIVERSITY OF IOWA   (United States)

^b NATIONAL HEART LUNG AND BLOOD INSTITUTE   (United States)

^c UNIVERSITY OF NORTH CAROLINA   (United States)

^d UNIVERSITY OF TEXAS SCHOOL OF PUBLIC HEALTH   (United States)

^e UNIVERSITY OF CINCINNATI COLLEGE OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ETHINYLESTRADIOL; LIPID; LIPOPROTEIN; MESTRANOL; ORAL CONTRACEPTIVE AGENT;

ADOLESCENCE; ADOLESCENT; BLOOD PRESSURE; CARDIOVASCULAR SYSTEM; CIGARETTE SMOKING; HUMAN; HUMAN CELL; LIPID BLOOD LEVEL; LIPOPROTEIN BLOOD LEVEL; NORMAL HUMAN; ORAL CONTRACEPTION; ORAL DRUG ADMINISTRATION; SMOKING;

ADOLESCENT; ADULT; BLOOD PRESSURE; CONTRACEPTIVES, ORAL; EDUCATIONAL STATUS; FEMALE; HUMANS; LIPIDS; LIPOPROTEINS; RISK; SMOKING; SOCIOECONOMIC FACTORS;

EID: 0018686606     PISSN: 00223476     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0022-3476(79)80311-X     Document Type: Article

References (28)

1. Sexual and contraceptive experience of young unmarried women in the United States 1976 and 1971
2. Contraceptive education for all teens, and services on request favored by most adults
3. Plasma lipid distributions in selected North American populations
4. Two factor index of social position
5. Altered plasma lipids associated with oral contraceptive or estrogen consumption
6. Blood lipoproteins in oral contraceptive users
7. Biochemical effects of oral contraceptives
8. Serum lipids during oral contraceptive exposure
9. Cardiovascular risk factors and the use of estrogens or estrogen-progestogen combinations
10. Oral contraceptives and serum lipids
11. Hemostatic, lipid, and blood-pressure profile of women on oral contraceptives containing 50 μg or 30 μg estrogen
12. Serum high-density-lipoprotein cholesterol in women using oral contraceptives, estrogens, and progestins
13. Oral contraceptives, renin, aldosterone, and high blood pressure
14. Oral contraceptives and blood pressure
15. Oral contraceptives, pregnancy, and blood pressure
16. Blood pressure after one year of oral contraception
17. Effect on hypertension and benign breast disease of progestogen component in combined oral contraceptives
18. Socioeconomic characteristics and methods of fertility control of female subscriber to the Kaiser Foundation health plan
19. Association between oral contraceptive and myocardial infarction, a review
20. High density lipoprotein as a protective factor against coronary heart disease
21. Reduced high density lipoprotein in women aged 40–41 using oral contraceptives
22. Serum cholesterol, lipoproteins, and the risk of coronary heart disease. The Framingham study
23. Medical aspects of oral contraceptives
24. New estimates of mortality associated with fertility control